These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6316367)

  • 1. Modification of tumor cell antigen.
    Kobayashi H
    Prog Clin Biol Res; 1983; 132E():305-14. PubMed ID: 6316367
    [No Abstract]   [Full Text] [Related]  

  • 2. Liposomes as a tool to study the role of membrane presentation in the immunogenicity of a MuLV-related tumor antigen.
    Gerlier D; Bakouche O; Dore JF
    J Immunol; 1983 Jul; 131(1):485-90. PubMed ID: 6190925
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
    Stackpole CW; Demsey A
    Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of immunity to murine leukemia (LSTRA) by Bacillus Calmette-Guérin.
    Bartlett GL; Kreider JW; Purnell DM
    Cancer Res; 1978 Dec; 38(12):4401-8. PubMed ID: 719627
    [No Abstract]   [Full Text] [Related]  

  • 5. Improved immunotherapy of a recombinant carcinoembryonic antigen vaccinia vaccine when given in combination with interleukin-2.
    McLaughlin JP; Schlom J; Kantor JA; Greiner JW
    Cancer Res; 1996 May; 56(10):2361-7. PubMed ID: 8625312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-leukaemic AkR mice are not tolerant to cells of leukaemia induced by Gross virus.
    Doré JF; Ajuria E; Mathé G
    Rev Eur Etud Clin Biol; 1970 Jan; 15(1):81-4. PubMed ID: 5442690
    [No Abstract]   [Full Text] [Related]  

  • 7. Virus-coded antigens in chemically induced leukemia.
    Pasternak G; Pasternak L
    Boll Ist Sieroter Milan; 1971; 50(3):192-8. PubMed ID: 5004411
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of tumor cell extracts in immunotherapy of murine EL-4 leukemia.
    Cantrell JL; McLaughlin CA; Ribi E
    Cancer Res; 1979 Apr; 39(4):1159-67. PubMed ID: 421199
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antigenicity of xenogenized tumor cells with special reference to amounts of virus-associated antigen (author's transl)].
    Yamaguchi H
    Hokkaido Igaku Zasshi; 1981 Jul; 56(4):439-48. PubMed ID: 7327520
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tumor rejection antigen and cancer immunotherapy].
    Matsutake T; Nakayama E
    Gan To Kagaku Ryoho; 1995 Nov; 22(13):1871-7. PubMed ID: 7487115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of the modifying effect of neuraminidase of the influenza virus on the development of Rauscher leukemia].
    Novichenko NL; Struk VI
    Eksp Onkol; 1984; 6(3):29-32. PubMed ID: 6499739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current enigmas in cancer research.
    Old LJ; Boyse EA
    Harvey Lect; 1973; 67():273-315. PubMed ID: 4351100
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor antigens recognized by T-lymphocytes in human cancers. New advances and therapeutic perspectives].
    Gaugler B; Olive D
    Pathol Biol (Paris); 1998 Dec; 46(10):771-8. PubMed ID: 9922993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outlook for the use of antitumor vaccines in the treatment and prevention of malignant neoplasms].
    Shuklinov VA; Shumilina VV
    Vopr Onkol; 1985; 31(8):3-10. PubMed ID: 3898578
    [No Abstract]   [Full Text] [Related]  

  • 16. Potentiation of in vivo model murine tumor destruction by combined immunoradiotherapy.
    Johnson TS
    Cancer Res; 1978 May; 38(5):1388-97. PubMed ID: 76513
    [No Abstract]   [Full Text] [Related]  

  • 17. [Some properties of viral reticulosarcomatosis in mice].
    Bergol'ts VM; Ter-Grigorov VS; Moskovkina OIa
    Vopr Onkol; 1970; 16(9):53-8. PubMed ID: 4320988
    [No Abstract]   [Full Text] [Related]  

  • 18. Discussion paper: experimental and clinical immunopharmacology data applicable to cancer immunotherapy.
    Mathé G; Schwarzenberg L; Halle-Pannenko O; Simmler MC
    Ann N Y Acad Sci; 1976; 277(00):467-84. PubMed ID: 826207
    [No Abstract]   [Full Text] [Related]  

  • 19. [Carcino-fetal antigens and tumor-immunotherapy].
    Renner H
    Fortschr Med; 1974 Feb; 92(5):175-8. PubMed ID: 4132198
    [No Abstract]   [Full Text] [Related]  

  • 20. Retroviral antigens and tumours.
    Evan GI; Lennox ES
    Br Med Bull; 1985 Jan; 41(1):59-62. PubMed ID: 2982448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.